FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:877-883 March 21, 2002 Number 12 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Bigger, J. T. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Patients with reduced left ventricular function after myocardial infarction are at risk for life-threatening ventricular arrhythmias. This randomized trial was designed to evaluate the effect of an implantable defibrillator on survival in such patients.

Methods Over the course of four years, we enrolled 1232 patients with a prior myocardial infarction and a left ventricular ejection fraction of 0.30 or less. Patients were randomly assigned in a 3:2 ratio to receive an implantable defibrillator (742 patients) or conventional medical therapy (490 patients). Invasive electrophysiological testing for risk stratification was not required. Death from any cause was the end point.

Results The clinical characteristics at base line and the prevalence of medication use at the time of the last follow-up visit were similar in the two treatment groups. During an average follow-up of 20 months, the mortality rates were 19.8 percent in the conventional-therapy group and 14.2 percent in the defibrillator group. The hazard ratio for the risk of death from any cause in the defibrillator group as compared with the conventional-therapy group was 0.69 (95 percent confidence interval, 0.51 to 0.93; P=0.016). The effect of defibrillator therapy on survival was similar in subgroup analyses stratified according to age, sex, ejection fraction, New York Heart Association class, and the QRS interval.

Conclusions In patients with a prior myocardial infarction and advanced left ventricular dysfunction, prophylactic implantation of a defibrillator improves survival and should be considered as a recommended therapy.

Source Information

From the Cardiology Unit of the Department of Medicine (A.J.M, W.Z., J.P.D, M.W.B., M.L.A.) and the Department of Biostatistics (W.J.H.), University of Rochester Medical Center, Rochester, N.Y.; the Division of Cardiology, University Hospital, Magdeburg, Germany (H.K.); the Cardiology Unit, Loyola University Medical Center, Maywood, Ill. (D.J.W.); Cardiology Associates, Good Samaritan Hospital, Los Angeles (D.S.C.); and the Department of Cardiology, Scripps Memorial Hospital, La Jolla, Calif. (S.L.H.).

Address reprint requests to Dr. Moss at the Heart Research Follow-up Program, Box 653, University of Rochester Medical Center, Rochester, NY 14642, or at heartajm{at}heart.rochester.edu.

Full Text of this Article

Related Letters:

Implantable Cardiac Defibrillators
Donaldson R. M. Jr., Stecker E. C., Pollack H. A., Carbajal E. V., Smith R. G., Cohen S. E., Gollapudi A. K., Spivack C., Moss A. J., Hall W. J., Zareba W.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:365-367, Aug 1, 2002. Correspondence

This article has been cited by other articles:

• van Veldhuisen, D. J., Maass, A. H., Priori, S. G., Stolt, P., van Gelder, I. C., Dickstein, K., Swedberg, K. (2009). Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 11: 1143-1151 [Abstract] [Full Text]  
• Pascale, P., Schlaepfer, J., Oddo, M., Schaller, M.-D., Vogt, P., Fromer, M. (2009). Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization. Europace 11: 1639-1646 [Abstract] [Full Text]  
• Belevych, A. E., Terentyev, D., Viatchenko-Karpinski, S., Terentyeva, R., Sridhar, A., Nishijima, Y., Wilson, L. D., Cardounel, A. J., Laurita, K. R., Carnes, C. A., Billman, G. E., Gyorke, S. (2009). Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death. Cardiovasc Res 84: 387-395 [Abstract] [Full Text]  
• Mishkin, J. D., Saxonhouse, S. J., Woo, G. W., Burkart, T. A., Miles, W. M., Conti, J. B., Schofield, R. S., Sears, S. F., Aranda, J. M. Jr (2009). Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge Time to Go Beyond the Initial Shock.. J Am Coll Cardiol 54: 1993-2000 [Abstract] [Full Text]  
• Goldberger, J. J., Passman, R. (2009). Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction The Results Are Not Shocking.. J Am Coll Cardiol 54: 2001-2005 [Abstract] [Full Text]  
• American College of Cardiology Foundation, , American Heart Association Task Force on Practice, , American Society of Echocardiography, , American Society of Nuclear Cardiology, , Heart Rhythm Society, , Society of Cardiovascular Anesthesiologists, , Society for Cardiovascular Angiography and Interve, , Society for Vascular Medicine, , Society for Vascular Surgery, , Fleisher, L. A., Beckman, J. A., Brown, K. A., Calkins, H., Chaikof, E. L., Fleischmann, K. E., Freeman, W. K., Froehlich, J. B., Kasper, E. K., Kersten, J. R., Riegel, B., Robb, J. F. (2009). 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. J Am Coll Cardiol 54: e13-e118 [Full Text]  
• 2007 WRITING COMMITTEE MEMBERS, , Fleisher, L. A., Beckman, J. A., Brown, K. A., Calkins, H., Chaikof, E. L., Fleischmann, K. E., Freeman, W. K., Froehlich, J. B., Kasper, E. K., Kersten, J. R., Riegel, B., Robb, J. F. (2009). 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 120: e169-e276 [Full Text]  
• Cheong, B. Y.C., Muthupillai, R., Wilson, J. M., Sung, A., Huber, S., Amin, S., Elayda, M. A., Lee, V.-V., Flamm, S. D. (2009). Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction. Circulation 120: 2069-2076 [Abstract] [Full Text]  
• Borleffs, C. J. W., van Welsenes, G. H., van Bommel, R. J., van der Velde, E. T., Bax, J. J., van Erven, L., Putter, H., van der Bom, J. G., Rosendaal, F. R., Schalij, M. J. (2009). Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease. Eur Heart J 0: ehp497v1-ehp497 [Abstract] [Full Text]  
• Breithardt, G. (2009). MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. Eur Heart J 30: 2551-2553 [Full Text]  
• Holcomb, M. R., Woods, M. C., Uzelac, I., Wikswo, J. P., Gilligan, J. M., Sidorov, V. Y. (2009). The Potential of Dual Camera Systems for Multimodal Imaging of Cardiac Electrophysiology and Metabolism. Exp. Biol. Med. 234: 1355-1373 [Abstract] [Full Text]  
• Duray, G. Z., Schmitt, J., Richter, S., Israel, C. W., Hohnloser, S. H. (2009). Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period. Europace 11: 1462-1468 [Abstract] [Full Text]  
• Kanoupakis, E. M., Manios, E. G., Vardas, P. E. (2009). Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers. Europace 11: 1434-1439 [Abstract] [Full Text]  
• Piccini, J. P., Zhang, M., Pieper, K., Solomon, S. D., Al-Khatib, S. M., Van de Werf, F., Pfeffer, M. A., McMurray, J. J.V., Califf, R. M., Velazquez, E. J. (2009). Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial. Eur Heart J 0: ehp425v1-ehp425 [Abstract] [Full Text]  
• Steinbeck, G., Andresen, D., Seidl, K., Brachmann, J., Hoffmann, E., Wojciechowski, D., Kornacewicz-Jach, Z., Sredniawa, B., Lupkovics, G., Hofgartner, F., Lubinski, A., Rosenqvist, M., Habets, A., Wegscheider, K., Senges, J., the IRIS Investigators, (2009). Defibrillator Implantation Early after Myocardial Infarction. NEJM 361: 1427-1436 [Abstract] [Full Text]  
• Borleffs, C. J. W., Scherptong, R. W.C., Man, S.-C., van Welsenes, G. H., Bax, J. J., van Erven, L., Swenne, C. A., Schalij, M. J. (2009). Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle. Circ Arrhythm Electrophysiol 2: 548-554 [Abstract] [Full Text]  
• Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N.A. M. III, Foster, E., Greenberg, H., Higgins, S. L., Pfeffer, M. A., Solomon, S. D., Wilber, D., Zareba, W., the MADIT-CRT Trial Investigators, (2009). Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. NEJM 361: 1329-1338 [Abstract] [Full Text]  
• Cowie, M. R., on behalf of the co-authors, (2009). Editorial: The economical challenge in the treatment of chronic heart failure: is primary prophylactic implantable cardioverter defibrillator therapy cost-effective in Europe?. Europace 11: 1407-1408 [Full Text]  
• McHale, B., Harding, S. A., Lever, N. A., Larsen, P. D. (2009). A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators. Europace 11: 1313-1316 [Abstract] [Full Text]  
• Meine, M., Smith, T., Hauer, R. N.W. (2009). The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe? Reply. Europace 11: 1408-1410 [Full Text]  
• McComb, J. M., Plummer, C. J., Cunningham, M. W., Cunningham, D. (2009). Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation rates. Europace 11: 1308-1312 [Abstract] [Full Text]  
• Redberg, R. F. (2009). Is What Is Good for the Gander Really Good for the Goose?. Arch Intern Med 169: 1460-1461 [Full Text]  
• Ghanbari, H., Dalloul, G., Hasan, R., Daccarett, M., Saba, S., David, S., Machado, C. (2009). Effectiveness of Implantable Cardioverter-Defibrillators for the Primary Prevention of Sudden Cardiac Death in Women With Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials. Arch Intern Med 169: 1500-1506 [Abstract] [Full Text]  
• Tung, R., Swerdlow, C. D. (2009). Refining Patient Selection for Primary Prevention Implantable Cardioverter-Defibrillator Therapy: Reeling in a Net Cast Too Widely. Circulation 120: 825-827 [Full Text]  
• van den Broek, K. C., Nyklicek, I., Denollet, J. (2009). Anxiety Predicts Poor Perceived Health in Patients With an Implantable Defibrillator. Psychosomatics 50: 483-492 [Abstract] [Full Text]  
• Kaul, S. (2009). Man Must Measure: Except for Cardiologists!. J Am Coll Cardiol Img 2: 1111-1113 [Full Text]  
• Marti-Almor, J., Cladellas, M., Bazan, V., Altaba, C., Guijo, M., Delclos, J., Bruguera-Cortada, J. (2009). Long-term mortality predictors in patients with chronic bifascicular block. Europace 11: 1201-1207 [Abstract] [Full Text]  
• Brignole, M. (2009). Are complications of implantable defibrillators under-estimated and benefits over-estimated?. Europace 11: 1129-1133 [Full Text]  
• Myerburg, R. J., Reddy, V., Castellanos, A. (2009). Indications for implantable cardioverter-defibrillators based on evidence and judgment.. J Am Coll Cardiol 54: 747-763 [Abstract] [Full Text]  
• Tereshchenko, L. G., Faddis, M. N., Fetics, B. J., Zelik, K. E., Efimov, I. R., Berger, R. D. (2009). Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression.. J Am Coll Cardiol 54: 822-828 [Abstract] [Full Text]  
• Knecht, S., Sacher, F., Wright, M., Hocini, M., Nogami, A., Arentz, T., Petit, B., Franck, R., De Chillou, C., Lamaison, D., Farre, J., Lavergne, T., Verbeet, T., Nault, I., Matsuo, S., Leroux, L., Weerasooriya, R., Cauchemez, B., Lellouche, N., Derval, N., Narayan, S. M., Jais, P., Clementy, J., Haissaguerre, M. (2009). Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study.. J Am Coll Cardiol 54: 522-528 [Abstract] [Full Text]  
• Genovesi, S., Valsecchi, M. G., Rossi, E., Pogliani, D., Acquistapace, I., De Cristofaro, V., Stella, A., Vincenti, A. (2009). Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant 24: 2529-2536 [Abstract] [Full Text]  
• Borleffs, C. J. W., van Erven, L., van Bommel, R. J., van der Velde, E. T., van der Wall, E. E., Bax, J. J., Rosendaal, F. R., Schalij, M. J. (2009). Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads. Circ Arrhythm Electrophysiol 2: 411-416 [Abstract] [Full Text]  
• Sivagangabalan, G., Pouliopoulos, J., Huang, K., Barry, M. A., Lu, J., Thomas, S. P., Ross, D. L., Thiagalingam, A., Kovoor, P. (2009). Simultaneous Biventricular Noncontact Mapping and Ablation of Septal Ventricular Tachycardia in a Chronic Ovine Infarct Model. Circ Arrhythm Electrophysiol 2: 441-449 [Abstract] [Full Text]  
• Israel, C. W. (2009). Do some implant too many defibrillators or others too few?. Europace 11: 982-984 [Full Text]  
• Task force members, , Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., Vardas, P. (2009). Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 11: 1097-1107 [Abstract] [Full Text]  
• Scott, P. A., Turner, N. G., Chungh, A., Morgan, J. M., Roberts, P. R. (2009). Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals. Europace 11: 1048-1051 [Abstract] [Full Text]  
• Lim, H. S., Lip, G. Y.H. (2009). Defibrillation testing in patients with atrial fibrillation. Europace 11: 1108-1109 [Abstract] [Full Text]  
• Zaman, S., Sivagangabalan, G., Narayan, A., Thiagalingam, A., Ross, D. L., Kovoor, P. (2009). Outcomes of Early Risk Stratification and Targeted Implantable Cardioverter-Defibrillator Implantation After ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Circulation 120: 194-200 [Abstract] [Full Text]  
• Estes, N. A. M. III (2009). The Challenge of Predicting and Preventing Sudden Cardiac Death Immediately After Myocardial Infarction. Circulation 120: 185-187 [Full Text]  
• de Bie, M. K., van Dam, B., Gaasbeek, A., van Buren, M., van Erven, L., Bax, J. J., Schalij, M. J., Rabelink, T. J., Jukema, J. W. (2009). The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. Eur Heart J 30: 1559-1564 [Abstract] [Full Text]  
• Digby, G. C., Daubney, M. E., Baggs, J., Campbell, D., Simpson, C. S., Redfearn, D. P., Brennan, F. J., Abdollah, H., Baranchuk, A. (2009). Physiotherapy and cardiac rhythm devices: a review of the current scope of practice. Europace 11: 850-859 [Abstract] [Full Text]  
• Stockburger, M., Celebi, O., Krebs, A., Knaus, T., Nitardy, A., Habedank, D., Dietz, R. (2009). Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing. Europace 11: 924-930 [Abstract] [Full Text]  
• LaPointe, N. M A., Stafford, J. A, Pappas, P. A, Al-Khatib, S. M, Anstrom, K. J (2009). Use of {beta}-Blockers in Patients with an Implantable Cardioverter Defibrillator. The Annals of Pharmacotherapy 43: 1189-1196 [Abstract] [Full Text]  
• Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P., Ferri, L., Calabrese, A., Vizzardi, E., Alfieri, O., Margonato, A. (2009). Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 11: 581-587 [Abstract] [Full Text]  
• Stein, K. M., Mittal, S., Gilliam, F. R., Gilligan, D. M., Zhong, Q., Kraus, S. M., Meyer, T. E. (2009). Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace 11: 734-740 [Abstract] [Full Text]  
• Cevik, C., Perez-Verdia, A., Nugent, K. (2009). Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11: 710-715 [Abstract] [Full Text]  
• Cowie, M. R., Marshall, D., Drummond, M., Ferko, N., Maschio, M., Ekman, M., de Roy, L., Heidbuchel, H., Verboven, Y., Braunschweig, F., Linde, C., Boriani, G. (2009). Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace 11: 716-726 [Abstract] [Full Text]  
• Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Bella, P. D., Hindricks, G., Jais, P., Josephson, M. E., Kautzner, J., Kay, G. N., Kuck, K.-H., Lerman, B. B., Marchlinski, F., Reddy, V., Schalij, M.-J., Schilling, R., Soejima, K., Wilber, D. (2009). EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 11: 771-817 [Full Text]  
• Meine, M., Smith, T., Hauer, R. N.W. (2009). The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe?. Europace 11: 689-691 [Full Text]  
• Menasche, P. (2009). Stem Cell Therapy for Heart Failure: Are Arrhythmias a Real Safety Concern?. Circulation 119: 2735-2740 [Abstract] [Full Text]  
• Nardi, P., Pellegrino, A., Scafuri, A., Colella, D., Bassano, C., Polisca, P., Chiariello, L. (2009). Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction.. Ann. Thorac. Surg. 87: 1401-1407 [Abstract] [Full Text]  
• Tang, G. H.L., Fremes, S. (2009). Invited commentary.. Ann. Thorac. Surg. 87: 1407-1408 [Full Text]  
• Tsai, V. W., Cooper, J., Garan, H., Natale, A., Ptaszek, L. M., Ellinor, P. T., Hickey, K., Downey, R., Zei, P., Hsia, H., Wang, P., Hunt, S., Haddad, F., Al-Ahmad, A. (2009). The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients: Results From a Multicenter Registry. Circ Heart Fail 2: 197-201 [Abstract] [Full Text]  
• Roes, S. D., Borleffs, C. J. W., van der Geest, R. J., Westenberg, J. J.M., Marsan, N. A., Kaandorp, T. A.M., Reiber, J. H.C., Zeppenfeld, K., Lamb, H. J., de Roos, A., Schalij, M. J., Bax, J. J. (2009). Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator. Circ Cardiovasc Imaging 2: 183-190 [Abstract] [Full Text]  
• Tomlinson, D. R., Bashir, Y., Betts, T. R., Rajappan, K. (2009). Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 11: 638-642 [Abstract] [Full Text]  
• Ricci, R. P., Quesada, A., Almendral, J., Arribas, F., Wolpert, C., Adragao, P., Zoni-Berisso, M., Navarro, X., DeSanto, T., Grammatico, A., Santini, M., on behalf of DATAS study Investigators, (2009). Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Europace 11: 587-593 [Abstract] [Full Text]  
• Curtis, J. P., Luebbert, J. J., Wang, Y., Rathore, S. S., Chen, J., Heidenreich, P. A., Hammill, S. C., Lampert, R. I., Krumholz, H. M. (2009). Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator. JAMA 301: 1661-1670 [Abstract] [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]  
• Schulz, N., Puschel, K., Turk, E. E. (2009). Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?. ICVTS 8: 444-448 [Abstract] [Full Text]  
• Baman, T. S., Gupta, S. K., Valle, J. A., Yamada, E. (2009). Risk Factors for Mortality in Patients With Cardiac Device-Related Infection. Circ Arrhythm Electrophysiol 2: 129-134 [Abstract] [Full Text]  
• Spencker, S., Coban, N., Koch, L., Schirdewan, A., Muller, D. (2009). Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 11: 483-488 [Abstract] [Full Text]  
• Santini, M., Russo, M., Botto, G., Lunati, M., Proclemer, A., Schmidt, B., Erdogan, A., Helmling, E., Rauhe, W., Desaga, M., Santi, E., Messier, M., Boriani, G. (2009). Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 11: 476-482 [Abstract] [Full Text]  
• Proclemer, A., Ghidina, M., Gregori, D., Facchin, D., Rebellato, L., Fioretti, P., Brignole, M. (2009). Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 11: 465-475 [Abstract] [Full Text]  
• Valk, S., Jordaens, L. (2009). Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction. Europace 11: 407-408 [Full Text]  
• Connelly, D.T. (2009). Current controversies in using electrical devices. Eur J Heart Fail Suppl 8: i21-i24 [Full Text]